The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yeramian Patrick D since 2023.
This trader's CIK number is 1358266.
At the time of last reporting, Yeramian Patrick D was the Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. (stock ticker symbol AMLX).
Also see all insider trading activities at Amylyx Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AMLX | 0 | $0 | 2,812 | $45,914 | 0 | $0 |
| 2023 | AMLX | 0 | $0 | 118,205 | $3,701,136 | 61,544 | $223,096 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-09 | AMLX | Sale | 2,812 | 16.33 | 45,914 |
| 2023-05-15 | AMLX | Sale | 11,965 | 29.03 | 347,355 |
| 2023-05-15 | AMLX | Option Ex | 11,965 | 3.62 | 43,373 |
| 2023-04-17 | AMLX | Sale | 49,579 | 30.74 | 1,523,909 |
| 2023-04-17 | AMLX | Option Ex | 49,579 | 3.62 | 179,723 |
| 2023-03-16 | AMLX | Sale | 54,627 | 32.14 | 1,755,766 |
| 2023-01-06 | AMLX | Sale | 2,034 | 36.43 | 74,106 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yeramian Patrick D (Chief Medical Officer of Amylyx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.